Company page

Janux Therapeutics, Inc.

Janux Therapeutics, Inc. is a public company traded under the ticker JANX in the American market. The company has a market capitalization of approximately $934.9 million. Janux focuses on developing innovative therapies to address unmet medical needs in cancer treatment.